Nearly 100 Cases Added to Federal DePuy Pinnacle Hip Lawsuit Litigation in November, Texas Proceeding Continues to Move Forward
One month, 100 DePuy Pinnacle hip lawsuit claims. That’s the count for the month of November in a federal litigation now pending in the U.S. District Court, Northern District of Texas, according to a Master Case List update on November 30th.
According to recent documents, a total of 5,293 cases over the DePuy Pinnacle hip replacement device have now been filed in the Texas proceeding over a version of the device that includes a metal Ultamet liner. Plaintiffs in these lawsuits say this component is prone to wear and tear and can lead to metallosis, pain, swelling and other serious side effects caused by the shedding of toxic metal ions in the recipient’s blood stream. Oftentimes, these complications may necessitate revision surgery to remove and replace the DePuy Pinnacle hip.
Given its metal-on-metal design, individuals who claim to have been injured as a result of the implant say a DePuy Pinnacle recall should be issued, based on its similarities to the now-recalled ASR hip replacement. This device was recalled after it was revealed by the British Joint and Hip Registry to fail early in an acceptably high number of recipients. Court documents show that 100 more cases have been filed against Johnson & Johnson and DePuy Orthopaedics in the federal Pinnacle lawsuit litigation since the last Master Case List update was issued on October 31. (In re: DePuy Orthopaedics Inc. Pinnacle Hip Implant Product Liability Litigation, MDL No. 2244)
All-Metal Version of Hip Replacement Discontinued, Does Not Classify as DePuy Pinnacle Recall
As the U.S. Food and Drug Administration (FDA) continues to investigate the safety of metal-on-metal hips, more and more recipients of this Pinnacle device may come forward to file lawsuits. In January 2013, the federal agency proposed new regulations that would require this class of devices to undergo rigorous pre-market safety testing in order to receive approval. Previously, manufacturers were able to have their products receive clearance through the agency’s 510(k) program, for which they only had to prove the hip to be substantially equivalent to one already on the market.
Recipients of the DePuy Pinnacle and ASR metal implants, as well as other similarly-designed devices have been advised by the FDA to undergo routine blood testing to monitor for elevated levels of metal ions. Partially fueled by the FDA’s growing involvement, a Bloomberg report published earlier this year indicates that DePuy announced in May that it would discontinue sales of its all-metal implants, including the version of the Pinnacle.
Contact a Lawyer at Bernstein Liebhard LLP to File a DePuy Pinnacle Lawsuit
Join the growing number of plaintiffs who have filed DePuy Pinnacle lawsuits after receiving an all-metal version of the hip replacement. Call us today at (877) 779-1414.